Gap (Bermuda) L.P. Centessa Pharmaceuticals PLC (CNTA) insider trading activity

CNTA Quotes by TradingView

Gap (Bermuda) L.P. is Director of Centessa Pharmaceuticals plc. Currently has a direct ownership of 9.68 Million shares of CNTA, which is worth approximately $167 Million. The most recent transaction as insider was on Jun 02, 2021, when has been sold 1,500,000 shares (ADSs) at a price of $20.0 per share, resulting in proceeds of $30,000,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 9.68M
0% 3M change
0% 12M change
Total Value Held $167 Million

GAP (Bermuda) L.P. Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 02 2021
BUY
Open market or private purchase
$30,000,000 $20.0 p/Share
1,500,000 Added 13.41%
9,681,818 ADSs
G(L

Gap (Bermuda) L.P.

Director
Hamilton, D0

Track Institutional and Insider Activities on CNTA

Follow Centessa Pharmaceuticals plc and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CNTA shares.

Notify only if

Insider Trading

Get notified when an Centessa Pharmaceuticals PLC insider buys or sells CNTA shares.

Notify only if

News

Receive news related to Centessa Pharmaceuticals plc

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on CNTA